Further studies in large cohorts of SLE patients are also needed to evaluate the association between IgA-AECA and other clinical manifestations such as skin, central nervous system, and serosa involvement; vasculitis; thromboembolism; and hematological abnormalities. The gene discussed is CD79A; the disease is systemic lupus erythematosus.